- Categories:About Us
- Time of issue:2021-04-13 09:01:30
1950, The company predecessor for Xinan Pharmaceutical Factory Laboratory was founded
1951, Vinyl chloride used for Anti-hookworm was successfully developed
1964, Chongqing Pharmaceutical Research was founded
1978, moved to company’s present location on Tushan Road
1987, Ranitidine was successfully developed
1989, Clindamycin was successfully developed, and then was successfully manufactured in our pilot workshop which afterwards was approved by FDA in 1994.
1992, Fluconazole was successfully developed
1994, Milrinone was successfully developed.
1997, First FDA approval on Clindamycin API in China was authorized to CPRI
2000, Chongqing Carelife Pharma, a joint venture of CPRI was founded
2002, Acquired by Shanghai FosunPharma Group
2009, CRPI invested a start-up pharma-tech company Chongqing Fochon Pharma to get hands on new drug development
2009, Hold wholly and control over Chongqing Kangle Pharma
2010, Sucrose iron, Pemetrexed disodium API were approved by FDA
2012, Construction of Changshou API manufacturing facility started
2015, Construction of Changshou API manufacturing facility completed and put into use.
Scan the QR code to read on your phone